Signal peptide peptidase: a potential therapeutic target for parasitic and viral infections.

Schwake, Christopher; Hyon, Michael; Chishti, Athar H

Schwake, Christopher; Hyon, Michael; Chishti, Athar H.

Afiliación

Schwake C; Department of Developmental, Molecular, and Chemical Biology, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA, USA.
Hyon M; Department of Developmental, Molecular, and Chemical Biology, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA, USA.
Chishti AH; Department of Developmental, Molecular, and Chemical Biology, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA, USA.

Expert Opin Ther Targets ; 26(3): 261-273, 2022 03.

Article en En | MEDLINE | ID: mdl-35235480

Asunto(s)

Inhibidores de la Proteasa del VIH; Parásitos; Virosis; Animales; Ácido Aspártico Endopeptidasas/metabolismo; Inhibidores de la Proteasa del VIH/farmacología; Humanos; Mamíferos/metabolismo; Virosis/tratamiento farmacológico

Palabras clave

Babesiosis; HIV protease inhibitor; leishmania; lopinavir; malaria; signal peptide peptidase; trypanosoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Parásitos / Virosis / Inhibidores de la Proteasa del VIH Límite: Animals / Humans Idioma: En Revista: Expert Opin Ther Targets Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google